Evidence-Based Complementary and Alternative Medicine / 2016 / Article / Fig 1

Research Article

Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis

Figure 1

Lesion progression (lesion size: mm2) observed during treatment and follow-up periods in Shiunko and placebo groups. The rate of lesion reduction during treatment period in the Shiunko group was significantly higher than placebo group (Wilcoxon Signed Rank test, ).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.